These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 1957722)

  • 41. Pathology of prostatic intraepithelial neoplasia and adenocarcinoma of the prostate: prognostic influences of stage, tumor volume, grade, and margins of resection.
    Epstein JI
    Semin Oncol; 1994 Oct; 21(5):527-41. PubMed ID: 7939746
    [No Abstract]   [Full Text] [Related]  

  • 42. Prostatic cancer--what to do? Staging and prognostic factors in the primary therapy decision.
    Faul P
    Eur Urol; 1992; 22(2):89-98. PubMed ID: 1478236
    [No Abstract]   [Full Text] [Related]  

  • 43. Carcinoma of the prostate: the therapeutic dilemma.
    Paulson DF
    Annu Rev Med; 1984; 35():341-72. PubMed ID: 6372662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenocarcinoma of the prostate.
    Von Eschenbach AC; Johnson DE
    Compr Ther; 1978 Aug; 4(8):18-26. PubMed ID: 688739
    [No Abstract]   [Full Text] [Related]  

  • 45. Iridium-192 implants in patients with large stage C prostate cancer.
    Brosman SA
    Prog Clin Biol Res; 1991; 370():281-90. PubMed ID: 1924461
    [No Abstract]   [Full Text] [Related]  

  • 46. [Determination of ER-D5 (estrogen receptor related antigen) in prostatic cancer and its significance].
    Ohishi M; Miyake K; Koshikawa T; Asai J; Murase T
    Hinyokika Kiyo; 1992 Jul; 38(7):789-96. PubMed ID: 1381866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer: results of long-term followup.
    Myers RP; Larson-Keller JJ; Bergstralh EJ; Zincke H; Oesterling JE; Lieber MM
    J Urol; 1992 Mar; 147(3 Pt 2):910-5. PubMed ID: 1538495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prostatic cancer presenting as palpable lymph node metastasis--report of three cases].
    Masuda H; Yamada T; Nagahama K; Nagamatsu H; Negishi T
    Hinyokika Kiyo; 1992 Nov; 38(11):1269-72. PubMed ID: 1485580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prostatic cancer--clinical and morphometric principles].
    Stamey TA
    Urologe A; 1991 Nov; 30(6):348-60. PubMed ID: 1771715
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical and pathological study of 152 cases of prostatic cancer].
    Kondoh I; Miura T; Shimura H; Harada M; Fujii H
    Hinyokika Kiyo; 1992 Jun; 38(6):671-6. PubMed ID: 1632321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [An atypical course of prostatic cancer in young patients].
    Budiak VA; Chudnyĭ AI; Soloveĭ PF; Vasilevitskaia AG; Fishman MM
    Vrach Delo; 1991 Dec; (12):94-6. PubMed ID: 1792791
    [No Abstract]   [Full Text] [Related]  

  • 52. Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging.
    Gleason DF; Mellinger GT;
    J Urol; 2017 Feb; 197(2S):S134-S139. PubMed ID: 28012760
    [No Abstract]   [Full Text] [Related]  

  • 53. [Prostatic adenocarcinoma: pathological stage C. I: Diagnosis, technical aspects and significance].
    Flam T; Zerbib M; Steg A; Debré B
    J Urol (Paris); 1991; 97(1):5-9. PubMed ID: 1707935
    [No Abstract]   [Full Text] [Related]  

  • 54. Node-positive prostate cancer: a call for level 1 evidence.
    Gandaglia G; Karnes RJ; Cozzarini C; Montorsi F; Briganti A
    Oncology (Williston Park); 2015 Feb; 29(2):118, 125, 141. PubMed ID: 25683833
    [No Abstract]   [Full Text] [Related]  

  • 55. Expectant management of localized prostatic cancer.
    Whitmore WF; Warner JA; Thompson IM
    Cancer; 1991 Feb; 67(4):1091-6. PubMed ID: 1991257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment options for patients with stage D1 (T0-3,N1-2,M0) adenocarcinoma of prostate.
    Zincke H; Utz DC; Thulé PM; Taylor WF
    Urology; 1987 Oct; 30(4):307-15. PubMed ID: 3660520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adenocarcinoma of the prostate. Stage-by-stage treatment alternatives.
    Soloway MS
    Postgrad Med; 1988 Nov; 84(7):44-6, 51-5. PubMed ID: 3054850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of pelvic lymphadenectomy in patients with prostatic adenocarcinoma.
    Cline WA; Kramer SA; Farnham R; Cox EB; Glenn JF; Hinshaw W; Paulson DF
    Urology; 1981 Feb; 17(2):129-31. PubMed ID: 7467012
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostate cancer in men less than 45 years old: influence of stage, grade and therapy.
    Benson MC; Kaplan SA; Olsson CA
    J Urol; 1987 May; 137(5):888-90. PubMed ID: 3573183
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term followup results after expectant management of stage A1 prostatic cancer.
    Zhang G; Wasserman NF; Sidi AA; Reinberg Y; Reddy PK
    J Urol; 1991 Jul; 146(1):99-102; discussion 102-3. PubMed ID: 1711592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.